Dr. Nakul Karkare is an orthopedic surgeon in Long Island, New York, and has been an active staff member with full clinician privileges at South Nassau Communities Hospital in Oceanside
Debunked Episode 26: A Conversation on How to Improve Healthcare
Last year, the first of Donald Trump’s second term as President, there were 2214 measles cases, according to U.S. Measles Tracker managed by Johns Hopkins Bloomberg School of Public Health.
How States Can Succeed Under the Rural Health Transformation Program
The scramble by states to file their Rural Health Transformation Program grant proposals is over and the first-year state awards have been announced. But the breakneck pace of RHTP has
When There’s No Appointment Available, Patients Are Opening ChatGPT
The mental health system has a gap problem. Not a gap in awareness — the clinical community understands the shortage, the waitlists, the cost barriers. The gap is in what
Pennsylvania Sues Chatbot Over Claims It Impersonates Doctors
Pennsylvania is now the second state to file a lawsuit against Character.ai, a Silicon Valley-based startup offering a platform that lets users create and interact with AI-generated chatbot characters. The
Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs
Odyssey Therapeutics continues the immunology journey of serial biotech entrepreneur Gary Glick, who is pursuing drugs that could offer advantages over many currently available medicines. The Odyssey CEO’s ventures have
Adapting Healthcare Payments While Facing Financial Pressure and Economic Uncertainty
Healthcare providers are facing an unprecedented convergence of financial pressure: rising uncompensated care, shifting coverage dynamics, and escalating administrative costs continue to erode already thin margins. For healthcare organizations, a
Healthcare Bankruptcies Rise in Q1: 6 Things to Know
The healthcare provider industry isn’t collapsing — but it is fragmenting, according to data from healthcare restructuring firm Gibbins Advisors. The firm published a report last week showing financial strain
Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy
Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S. market. According
Transforming CTMS: An Operating Layer for Real-Time Trial Execution
Clinical Trial Management Systems (CTMS) were designed to make trial execution inspectable and compliant, and that role remains the backbone of operational control. They are built to log visits, record









